至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Viruslike Particles Encapsidating Respiratory Syncytial Virus M and M2 Proteins Induce Robust T Cell Responses.

ACS Biomater Sci Eng. 2016; 
SchwarzBenjamin,MorabitoKaitlyn M,RuckwardtTracy J,PattersonDustin P,AveraJohn,MiettinenHeini M,GrahamBarney S,DouglasTr
Products/Services Used Details Operation
Molecular Biology Reagents The plasmid inserts were confirmed by DNA sequencing (GenScript and Eurofins MWG Operon). Get A Quote

摘要

Subunit vaccines provide a safe, focused alternative to conventional vaccines. However, these vaccines often require significant adjuvants and are particularly hard to target toward cytotoxic T lymphocyte (CTL) immunity. Viruslike particles (VLPs) provide biomaterial scaffolds with pathogen-like polyvalent structures making them useful platforms for biomimetic antigen delivery to the immune system. Encapsidation of antigens within VLPs has been shown to enhance antigen availability for CD8 T cell responses. Here, we examine the potential to generate complex responses to multiple subunit antigens localized within the same VLP particle. Two proteins of respiratory syncytial virus (RSV) with well-characteriz... More

关键词

CD8+ T cell immunity,respiratory syncytial virus,subunit vaccine,tissue-resident memory T cells,viruslike part